Table: Hisamitsu - 6-MTH group results
Oct 10 (Reuters)-
Hisamitsu Pharmaceutical Co Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Aug 31, 2019 Aug 31, 2018 Feb 29, 2020
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 63.40 69.40 143.50
(-8.6 pct) (-5.6 pct) (+0.1 pct)
Operating 10.19 11.25 22.90
(-9.4 pct) (-11.1 pct) (+2.8 pct)
Recurring 10.64 12.01 25.50
(-11.4 pct) (-6.7 pct) (+3.5 pct)
Net 7.55 9.16 19.40
(-17.6 pct) (-2.4 pct) (+1.0 pct)
EPS 91.37 yen 109.46 yen 234.83 yen
EPS Diluted 91.27 yen 109.36 yen
Ann Div 82.50 yen 83.00 yen
-Q2 div 41.50 yen 41.25 yen
-Q4 div 41.25 yen 41.50 yen
NOTE - Hisamitsu Pharmaceutical Co Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T
Recent news on Hisamitsu Pharmaceutical Co
See all newsTable: Hisamitsu -2025/26 group results
Table: Hisamitsu -2025/26 parent results
Brief: Hisamitsu Pharmaceutical Co Inc - To Retire Treasury Shares Worth 6.34% Of Outstanding Stock On May 12
Brief: Hisamitsu Pharmaceutical Co Inc - Tender Offer Of Company By Taiyo Kosan Successfully Completed
Japan's Hisamitsu Pharmaceutical plans $2.55 billion MBO